Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
PRO-QUETIAPINE PRO DOC LIMITEE Resolved 25MG Updated Report 2025-03-15 247812
SODIUM CHLORIDE INJECTION USP ICU MEDICAL CANADA INC Actual shortage 9MG Updated Report 2025-03-15 251160
!!T3 ONCASPAR SERVIER CANADA INC Actual shortage 750UNIT Updated Report 2025-03-15 241135
ORILISSA ABBVIE CORPORATION Resolved 200MG Updated Report 2025-03-15 245420
VENTOLIN DISKUS GLAXOSMITHKLINE INC Anticipated shortage 200MCG New Report 2025-03-14 252627
FLOVENT DISKUS GLAXOSMITHKLINE INC Anticipated shortage 100MCG New Report 2025-03-14 252624
APO-FLUOXETINE APOTEX INC Resolved 10MG Updated Report 2025-03-14 245456
APO-FLUOXETINE APOTEX INC Resolved 20MG Updated Report 2025-03-14 245459
APO-CANDESARTAN TABLETS APOTEX INC Resolved 8MG Updated Report 2025-03-14 249077
APO-NAPROXEN APOTEX INC Resolved 500MG Updated Report 2025-03-14 248489

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
BETOPTIC S NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 0.25% New Report 2025-03-11 252361
PAXIL TAB 10MG GLAXOSMITHKLINE INC To be discontinued 10MG Updated Report 2025-03-07 224405
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC Discontinued 200MG Updated Report 2025-02-20 233049
STERILE WATER FOR INJECTION USP ICU MEDICAL CANADA INC Discontinued 100% Updated Report 2025-02-20 199997
SODIUM CHLORIDE INJECTION USP ICU MEDICAL CANADA INC Discontinued 4.5MG Updated Report 2025-02-20 246144
TROSEC SUNOVION PHARMACEUTICALS CANADA INC To be discontinued 20MG Updated Report 2025-02-10 250062
KIVEXA VIIV HEALTHCARE ULC To be discontinued 300MG 600MG Updated Report 2025-02-07 238375
CASODEX ASTRAZENECA CANADA INC Discontinued 50MG Updated Report 2025-02-07 231878
SKYRIZI ABBVIE CORPORATION Discontinued 75MG Updated Report 2025-02-06 248607
NUTROPIN AQ NUSPIN 5 HOFFMANN-LA ROCHE LIMITED Discontinued 5MG Updated Report 2025-02-01 232071
NUTROPIN AQ NUSPIN 10 HOFFMANN-LA ROCHE LIMITED Discontinued 10MG Updated Report 2025-02-01 232079
NUTROPIN AQ NUSPIN 20 HOFFMANN-LA ROCHE LIMITED Discontinued 20MG Updated Report 2025-02-01 232086
NRA-FLECAINIDE NORA PHARMA INC Discontinued 100MG New Report 2025-01-29 249046
NRA-FLECAINIDE NORA PHARMA INC Discontinued 50MG New Report 2025-01-29 249043
PMSC-METFORMIN PHARMASCIENCE INC To be discontinued 850MG New Report 2025-01-28 248801
PMSC-METFORMIN PHARMASCIENCE INC To be discontinued 500MG New Report 2025-01-28 248798
APO-AMITRIPTYLINE APOTEX INC To be discontinued 50MG Updated Report 2025-01-27 247469
CARBOLITH BAUSCH HEALTH, CANADA INC. Discontinued 150MG Updated Report 2025-01-23 247417
ACULAR LS ABBVIE CORPORATION To be discontinued 0.4% New Report 2025-01-23 248365
TARO-ZOLEDRONIC ACID TARO PHARMACEUTICALS INC Discontinued 5MG New Report 2025-01-21 248172